Search

everythinglearnresearchcommunity

for

Search:↓

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

A patient with granuloma annulare experienced both isotopic and isomorphic responses, with skin lesions responding to steroids but relapsing after stopping treatment.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Ruxolitinib can cause a delayed skin reaction on the nose.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Children's Serum Sickness-Like Reaction is often linked to antibiotics, especially amoxicillin, and involves symptoms like rash, fever, and joint issues.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

A woman with Rhupus and Rowell syndrome was treated successfully with medication adjustments.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

A woman had a rare skin condition with recurring painful nodules that heal in 6 weeks, often without needing treatment.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

The patient likely has Chrousos syndrome, a rare condition causing insensitivity to glucocorticoids, requiring high-dose dexamethasone treatment.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Dupilumab can cause unexpected scalp issues, so early symptom recognition is important to avoid hair loss.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Thalidomide improved lupus symptoms but caused nerve damage in some patients.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Intradermal testing can better detect corticosteroid allergies than patch testing.

A man developed a skin reaction from metronidazole, which improved after stopping the drug and starting steroids.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.